chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the back of his neck like a squeezing feeling; Fatigue; Headaches; Pain in injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (In the back of his neck like a squeezing feeling), FATIGUE (Fatigue), HEADACHE (Headaches) and VACCINATION SITE PAIN (Pain in injection site) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced NECK PAIN (In the back of his neck like a squeezing feeling), FATIGUE (Fatigue), HEADACHE (Headaches) and VACCINATION SITE PAIN (Pain in injection site). On 12-Feb-2021, FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain in injection site) had resolved. At the time of the report, NECK PAIN (In the back of his neck like a squeezing feeling) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
SHAKING; CHILLING; INJECTION BURNED IMMENSELY AS IT WAS INJECTED; HEADACHE; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's past medical history included: radiofrequency ablation, and cryoablation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the patient experienced chilling, shaking, injection burned immensely as it was injected, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and the outcome of chilling, shaking and injection burned immensely as it was injected was not reported. This report was non-serious. This case, from the same reporter is linked to 20211233591. This report was associated with a product quality complaint:90000207187.
I got pain on my right knee and was not able to bend the knee completely. I still cannot bend the knee completely.
patient had fever 100 F cough "feeling" sick, he had to call in sick from work for a few days, he will be back to work on 9/18/22
Body aches; feeling really sick; soreness and pain in injection site; Pain I had it was my arm, it was very sore; This is a spontaneous report from a contactable consumer (patient) via medical information team.  A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number, Expiry date: unknown), via an unspecified route of administration on 17Jun2021 as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received vaccine last Thursday, 17Jun2021 and experienced soreness, and pain in injection site. So, her question was, she got her vaccine on Thursday and the only pain she had it been her arm, it was very sore but all it seems very general and Friday on 18Jun2021, next day she cooked the spaghetti, and she had a glass of wine with her dinner, was alcohol allowed or not allowed with vaccine, She stated that she had lot of pain, her body aches a lot and she was feeling really sick yesterday, even after taking Tylenol does not help. Patient mentioned that someone told her that wine should not be taken with other vaccines. She spoke with the pharmacy, and they had no say about it. She asked if alcohol had any interactions with the Pfizer BioNTech COVID-19 vaccine. Patient hung up the call abruptly. Patient was unwilling to complete the report. Hence, limited information available. Outcome of the events was unknown.  Information about batch/Lot number has been requested.
Pt presented with swelling and redness of the upper arm to the elbow.  No treatment prescribed.
Patient reported no symptomatic adverse experiences/No additional AE; Nurse calling to report administration of expired PNEUMOVAX-23 to patient on 04-APR-2023. Caller stated that the product had no previous temperature excursion and expired on 25-MAR-2023; This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were no reported.  On 04-APR-2023, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml once (lot # U027357, has been verified to be a valid lot number for pneumococcal vaccine, polyvalent (23-valent), expiration date reported and validated as 25-MAR-2023) (route of administration and anatomical location were not provided) as prophylaxis (expired dose administered). The patient did not report symptomatic adverse experiences (no adverse event). No temperature excursions were reported. A "MIR" for revaccination was requested.
Had Flu shot 11/29/16 - SOB - tiredness fatigue - lightheaded - body aches - same evening -Friday itching and Sunday noticed hives -Monday hives subsided.
6.17.09 @ 2:30 pm immunization given. 6.17.09 @ ~ 5:30 pm --> fever (1m 104) - Hives @ 11:00 pm. No facial swelling or difficulty breathing. History of URIS X X 3 weeks concurrently.
Approximately 6 weeks after receiving my booster on 11/15/21, I woke up with a clogged left ear, tinnitus in left ear, balance and dizziness, terrible neck pain and brain fog .  I still have these symptoms almost 11 months later.  This vaccine is poison and you ruined the lives of so many.
After recieving the Gardasil vaccine the patient became very dizzy and lightheaded, also saying that here throat was feeling "tingling" Dr. determined that she was having an anaphylactic reaction to the vaccine and administered Epi.  After about 45 min the patient was feeling better, and was released into the care of her mother.
Both arms still painful aching continually. Some days more than others.  had a test with dye and it was very painful .
16 year old client received Moderna as first dose vaccine; Moderna not approved for individuals less than 18 years of age.
No adverse event; Administered with expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine).  No concomitant medication were reported. A total of 35 doses were given from 4 vials.  The vial was initially stored in refrigerator was on 07-Jun-2022.  The date for the patient vaccine administration was not known, and it was also unknown whether the patient took first, second or first and second booster doses.  It was reported that a total of 35 doses were given from 4 vials for approximately 40 patients. The dates on which vaccinations were given from 01-Apr-22, 05-Apr-22, 08-Apr-22, 06-Apr-22, 11-Apr-22, 12-Apr-22, 13-Apr-22, 14-Apr-22, 22-Apr-22, 09-Jun-22, 10-Jun-22, 13-Jun-22, 18-Jun-22, and 22-Jun-22. The vial had not undergone any temperature excursions. No treatment medications were reported.
This case was reported by a consumer via call center representative and described the occurrence of trigeminal neuralgia in a adult female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included cancer. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced trigeminal neuralgia and facial neuralgia. On an unknown date, the outcome of the trigeminal neuralgia was not recovered/not resolved and the outcome of the facial neuralgia was unknown. It was unknown if the reporter considered the trigeminal neuralgia and facial neuralgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient developed trigeminal neuralgia or face nerve pain after receiving a dose of SHINGRIX and because of this, the patient did not take 2nd dose of SHINGRIX. The patient believed that because she had cancer, the cancer was pressing against the nerve which was why she was diagnosed with this condition. The patient refused to provide any additional details or answer any further questions.
fever started at 102.5 deg F, body shaking and sweating in the middle of the night.  woke up next morning with fever, headache, body aches, loss of appetite.  took tylenol throughout the day to bring fever down to 101 deg F.  sleep most of the day. second day woke up and temp was back down to 99.4 deg F and continued to drop throughout that day.  body aches lessened.  by the third day, i was back to normal.
The patient medical history and concomitant medications were not reported. On 12Mar2021 same day after vaccination of first dose, the patient started experiencing his arm feels painful, felt strain when he lifts this arm, felt like there is something inside the arm, but cannot describe it further. The patient asked if these lingering symptoms were reported as side effect to the vaccine and if he should consult a doctor for them. The patient received both the doses of vaccine. The outcome of the events was reported as unknown. No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Pt presented to ED with c/o nausea, shaking, chills and loss of appetite with onset approximately 2-3 hours post vaccination
Parent-(mother) phoned the Health Department and informed to me that her daughter vomited today and she has contacted her doctor and needed to tell her doctor what vaccinations she recieved 1/9/06.She informed that her daughter has at this time of the call stopped vomiting. I gave her list of all vaccines that were given on this date and instructed to give the list to her infants doctor. I instructed to call us at the Health Department to follow up with us after she has followed up with doctor. Parent verbilizes understanding to talk to her physician.
ER on 31MAY2021, symptoms of covid. fever and body pains. bloated and weary and low fever. did bloodwork and autoimmune, UTI infection. No covid and liver problems. I couldn't see the liver specialist.
Patient received second Moderna vaccine at 12:15 on Tuesday in her left arm.  She started feeling significant symptoms the next morning and went to bed.  Her symptoms included headache, nausea, tightness in upper chest, difficultly breathing, achy body, exhausted.  Symptoms improved by Thursday at noon, enough to get out of bed.  New symptoms on Thursday were painful to touch left side of neck, not able to get comfortable, restless hard to sleeping.  On Friday awoke up with swollen neck, enlarged left neck lymph nodes and dizzy. Went to see Employee Health Nurse recommended that patient go home with instructions to follow up Primary PCP on Monday if symptoms don't improve
Narrative: Per PCP note 4/20/21: Received COVID-19 vaccine #2 yesterday. Mild feverishness chills shortness of breath last night for several hours. Vital signs stable today. No acute distress. Patient alert and conversant.
Pt did not have an adverse event, but there was a temperature excursion of the J &  J vaccine vial. Vaccine was taken out of fridge at 12:03pm, then 1 dose drawn up at around 12:11pm. I then accidentally left the vial out at room temperature for around 35 minutes. At this point I then put the vial back in the fridge. I asked a couple other pharmacists if okay to use and they said yes, so I drew up more doses around 3:30pm (this is an estimate). I also drew up this particular pt's dose around 5:45pm & then administered. All doses were administered within the 6 hour timeframe. Per conversation w/ manufacturer it was out at room temperature longer than what is suggested (i.e. probably around 5 minutes longer than it should have been out of fridge), so the representative at the mfr is sending this to the safety team to find out if re-vaccination may be necessary.
The Moderna lot number 059M21A had an expiration of 10/15/22, however it was recieved after ordering on 5/10/22 and so had a 30 day use by window to administer. This particialur dose fell 10 days after the use by date. The patient did not have any reactions, did not require any recovery time, and still benefits from the protection the vaccine provides.
- She could not talk suddenly(Around 9 hour after vaccination) - Call 911: Blood pressure  test , 911 suggest they she need to one day monitoring) - She had a high fever and muscle aches that night, so  took Tylenol.
Patient become light headed within minutes of vaccination. BP 12/83, HR 88. Resolved on its own. CG left in stable condition.
1002-BP-122/86, SaO2-98% RA, P-103  Client complains of throat tightness. Sweaty palms. No hives or redness noted. 911 called.  Client relates feels like ,"knot in throat." Client A&Ox3.  Client able to talk and swallow. Client drinking water. No Epi administered. 1005-BP-118/68, SaO2, 99% RA, P-105 Clients throat still feels tight. No change in status. lungs clear. No Epi administered. 1010-EMT arrived. Client refused to go to ER in Ambulance. Client has no insurance. Clients throat remains tight. Lungs remain clear. No change in status. Client responsive and talking. Client not in respiratory distress. No epi administered. Nurse and EMT highly recommend client be assessed in ER. Client will have husband pick her up and bring her to ER for further follow up. 1030-BP-132/82, SaO2-98% RA, P-88 Client remains stable with no changes. Client still complains of tight throat. Client to go to ER once husband picks her up.  1110-Husband arrived. Nurse gave husband report on situation. Both client and husband escorted to front doors. Husband will be taking client to ER for further follow up for tightness in her throat.
Person describes not feeling well, dizzy after receiving vaccine. She says she has not eaten all day. She said her daughter made her anxious on the way here by speeding.
non-stop irregular heartbeat; This side affect affects my daily activities; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Apr2021 10:00 (Lot number: EW0176) at the age of 60 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure under controlled" (unspecified if ongoing), notes: Other medical history: high blood pressure under controlled. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Lot number: ER8729,, Administration date: 06Apr2021,, time: 12:30 PM,, Dose number: 1,, Vaccine location: Left arm), administration date: 06Apr2021, for COVID 19 IMMUNISATION, reaction(s): "irregular heartbeat". The following information was reported: HEART RATE IRREGULAR (non-serious) with onset 27Apr2021 14:00, outcome "not recovered", described as "non-stop irregular heartbeat"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 27Apr2021 14:00, outcome "not recovered", described as "This side affect affects my daily activities". The events "non-stop irregular heartbeat" and "this side affect affects my daily activities" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of heart rate irregular, loss of personal independence in daily activities.  Additional information: It was reported on 27Apr2021,4hrs after receiving 2nd dose of the Covid19 vaccine, patient had been experiencing almost non-stop irregular heartbeat, even after taking rest. This side effect affects her daily activities.  No follow-up attempts are possible. No further information is expected.
Information has been received from a medical assistant and physician concerning a 21 year old female with no pertinent medical history and no drug reactions/allergies who on 13-MAY-2008 was vaccinated subcutaneous with a 0.5 ml first dose of VARIVAX (Merck) (LOT # 659425/1916U).  There was no concomitant medication.  The patient developed an injection site reaction 9 days later.  The patient was seen on 23-MAY-2008 when the arm was red, swollen, and hot to touch at the injection site.  There was a large welt at the site.  The patient also had pain at the injection site.  There was no report of fever.  The physician did send the patient to the emergency room for an evaluation, the patient was not admitted.  White blood cell count was done with the result of 7.8.  Subsequently, the patient recovered from the events.  Additional information is not expected.
This spontaneous report as received from a pharmacist refers to a 74 year old male patient. The patient's pertinent current condition included skin cancer. On 10-APR-2014 the patient was vaccinated with a dose of ZOSTAVAX , 0.65 ml/once, lot # J011549, expiration date 19-DEC-2014, subcutaneously. Approximately on 13-APR-2014, within three days, the patient developed itching on palms and between his fingers. No treatment was given for the event. The patient did not seek medical attention. Event remained ongoing and patient would be consulting dermatologist in the future. The outcome of event was reported as not recovered/not resolved. The causality between event and therapy was not reported. Additional information has been requested.
red bumps on her fingers; itching; swelling; strong chills; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (strong chills), HEADACHE (headache), RASH PAPULAR (red bumps on her fingers), PRURITUS (itching) and PERIPHERAL SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026220A) for COVID-19 vaccination.     No Medical History information was reported.     On 08-Jan-2021 at 2:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced CHILLS (strong chills) and HEADACHE (headache). On 11-Jan-2021, the patient experienced RASH PAPULAR (red bumps on her fingers), PRURITUS (itching) and PERIPHERAL SWELLING (swelling). At the time of the report, CHILLS (strong chills), HEADACHE (headache), RASH PAPULAR (red bumps on her fingers), PRURITUS (itching) and PERIPHERAL SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient saw a Dermatologist, but no treatment for symptoms were reported.   No concomitant medications are were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (strong chills), HEADACHE (headache), RASH PAPULAR (red bumps on her fingers), PRURITUS (itching) and PERIPHERAL SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026220A) for COVID-19 vaccination.     No Medical History information was reported.     On 08-Jan-2021 at 2:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced CHILLS (strong chills) and HEADACHE (headache). On 11-Jan-2021, the patient experienced RASH PAPULAR (red bumps on her fingers), PRURITUS (itching) and PERIPHERAL SWELLING (swelling). At the time of the report, CHILLS (strong chills), HEADACHE (headache), RASH PAPULAR (red bumps on her fingers), PRURITUS (itching) and PERIPHERAL SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient saw a Dermatologist, but no treatment for symptoms were reported.   No concomitant medications are were reported.
About six minutes after shot, I experienced a sudden drop in blood pressure and heart rate, became dizzy, faint, and disoriented and experienced a period of complete blindness for 1-2 minutes. Paramedics were sent to my vehicle, they laid me back, took vitals and assured me that eyesight would return, which it did. They monitored me for 30 minutes and gave me a granola bar which I ate. When I was stable, I drove home.
I got sick after every flu shot until I got the egg free one; Initial information received on 24-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.  This case involves patient with unknown demography who got sick (illness), after receiving vaccine INFLUENZA VACCINE.  The patient's past vaccination included flu shot after which he/she turned sick.  Medical history, medical treatment(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sickness (illness) (Unknown latency) following the administration of INFLUENZA VACCINE. It was reported that after every flu shot patient got sick until he/she got the egg free one.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was not reported for the event illness.  There will be no information on the batch number for this case.
Severe pain at injection site on deltoid muscle of left arm. Pain became increasingly severe and radiated throughout shoulder joint until approximately 9 PM. Pain subsided gradually the next day and was only mildly uncomfortable by 5 PM.
Woke up at around 5am to severe chest pain and difficulty breathing (shortness of breath).  The condition continued through out the day requiring me to sit in a way that it would alleviate the pain and reduce the shortness of breath.
heavy headache; high fever; shaking; nausea; This is spontaneous report from a contactable consumer (patient) from Regulatory Authority. A female patient of an unspecified age received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 31Mar2021 as dose 1, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced heavy headache, high fever, shaking, and nausea. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.